学术探索
学术期刊
新闻热点
数据分析
智能评审

TREATMENT STRATEGIES FOR EXTENSION OF LEVODOPA EFFECT

被引：22
作者：
LEWITT, PA [1 ]
机构：
[1] WAYNE STATE UNIV, DETROIT, MI 48202 USA
来源：
NEUROLOGIC CLINICS | 1992年 / 10卷 / 02期
关键词：
D O I：
10.1016/S0733-8619(18)30224-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：511 / 526
页数：16
相关论文
共 112 条
[1]  
[Anonymous], 1981, MOV DISORD
[2]   PHENYLETHYLAMINE - EVIDENCE FOR A DIRECT, POSTSYNAPTIC DOPAMINE-RECEPTOR STIMULATING ACTION [J].
ANTELMAN, SM ;
EDWARDS, DJ ;
LIN, M .
BRAIN RESEARCH, 1977, 127 (02) :317-322
[3]   TURNOVER OF BRAIN MONOAMINE-OXIDASE MEASURED INVIVO BY POSITRON EMISSION TOMOGRAPHY USING L-[C-11]DEPRENYL [J].
ARNETT, CD ;
FOWLER, JS ;
MACGREGOR, RR ;
SCHLYER, DJ ;
WOLF, AP ;
LANGSTROM, B ;
HALLDIN, C .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (02) :522-527
[4]   METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE [J].
BIANCHINE, JR ;
CALIMLIM, LR ;
MORGAN, JP ;
DUJUVNE, CA ;
LASAGNA, L .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :126-+
[5]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .4. PRODRUGS OF L-DOPA [J].
BODOR, N ;
SLOAN, KB ;
HIGUCHI, T ;
SASAHARA, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (11) :1435-1445
[6]   PSYCHIATRIC EFFECTS OF SELEGILINE [J].
BOYSON, SJ .
ARCHIVES OF NEUROLOGY, 1991, 48 (09) :902-902
[7]   CONTROLLED-RELEASE LEVODOPA CARBIDOPA .3. SINEMET CR5 TREATMENT OF RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE [J].
CEDARBAUM, JM ;
HOEY, M ;
KUTT, H ;
MCDOWELL, FH .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (02) :168-173
[8]   CONTROLLED-RELEASE LEVODOPA CARBIDOPA .1. SINEMET CR3 TREATMENT OF RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE [J].
CEDARBAUM, JM ;
BRECK, L ;
KUTT, H ;
MCDOWELL, FH .
NEUROLOGY, 1987, 37 (02) :233-241
[9]   EFFECT OF SUPPLEMENTAL CARBIDOPA ON BIOAVAILABILITY OF L-DOPA [J].
CEDARBAUM, JM ;
KUTT, H ;
DHAR, AK ;
WATKINS, S ;
MCDOWELL, FH .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :153-159
[10]   SUSTAINED ENTERAL ADMINISTRATION OF LEVODOPA INCREASES AND INTERRUPTED INFUSION DECREASES LEVODOPA DOSE REQUIREMENTS [J].
CEDARBAUM, JM ;
SILVESTRI, M ;
KUTT, H .
NEUROLOGY, 1990, 40 (06) :995-997
12345678910